I have been beating the drum for transparency of cost information before granting exclusivity for drugs via patents. With a patent, companies can charge what the market will bear and have demonstrated they will do so on particular drugs such as insulin, Vimovo, EpiPens, etc. as well as other drugs identified in recent papers on Drug Pricing also. The following chart depicts cancer drug Sales Income as it relates to R & D Costs. It is an example of...
Read More »Preventing Surprise Medical Bills
The idea I have is not to be surprised. I am a careful patient who asks a lot of questions and also advocate for myself. I have refused treatment when they use drugs which may threaten my health further (Heparin). I am also not well liked by the bloodsuckers who come in to draw blood and stab me through the vein for two weeks and destroyed my left arm in the process. Ask them questions and do not be so willing to accept treatment (if cognizant) until they...
Read More »Pharma Price Increases 2020
As reported by Market Watch and Axios, drug prices are on the rise the beginning of 2020. The increases exceed the 2% inflation the nation has been incurring and the 3.4% growth in wages recently incurred by nonsupervisory labor. According to Market Watch, overall drug pricing will rise 5.8% at the start of 2020 due to price increases. This is about the same as Medical CPI. Fortune Magazine; “The price hikes are almost all below 10%, with the median price...
Read More »PPACA Healthcare Information
Of the 16.7 million uninsured people who could be shopping on the Marketplace whether or not they are eligible for a subsidy; a Kaiser Family Foundation analysis estimates 4.7 million of the uninsured Americans are eligible for free ($0 premiums) Bronze plans in the ACA marketplace. The 4.7 million is also a bit less than half of the uninsured who are eligible for marketplace subsidies, according to a 2017 Kaiser estimate. Bronze plans have an average...
Read More »Michigan Senate and House Majority Republicans Will Usurp the Public’s Right to Vote on an Abortion Ban
As I pointed out in a public meeting, Republicans have had control of the Michigan Senate since 1992, the House two-thirds of the time, and the governorship two of 3 times up till Gretchen Whitmer came to office. Yet under the control of Republicans, the state’s infrastructure is crumbling, its economy has decreased when compared to other nearby competitive states, and employment Participation Rate still has not returned to what it was pre-2008 when the...
Read More »NAFTA Revision, H.R. 1865, and Biologics (Pharma) Switcheroo
Sigh . . . If the general public has not caught it, there are some of us who watch the political mechanizations by commercial healthcare to improve their lot in Congress. I know the public has not caught this switcheroo in Congress causing them to look good (and boast of it) in removing new drug exclusivity from NAFTA. What we have missed is it was granted in H.R. 1865 instead and for a longer period of time to boot. Read on to see how this was...
Read More »John Lewis should read this
American hero John Lewis has Pancreatic Cancer. He should look at these two studies of the only treatment that has actually worked and a similar treatment. Also read this article in The Lancet. and in particular “Of the 18 patients given the maximum tolerated dose, 11 (61%) achieved an objective (complete or partial) response.” American heroine Ruth Bader Ginsburg might also be interested if she has a relapse. ...
Read More »Focusing on Congressional Efforts to Control Healthcare Pricing, They Do Not
Perhaps, I am on the wrong side of the argument on how to control healthcare costs of which one proposed solution is a part of the latest budget bill passed in a bipartisan effort in Congress on December 19, 2019. Others may disagree with me on my thoughts. What was passed was superficial and will not fix the rising cost of healthcare which drives increased healthcare insurance deductibles and premiums. Oh, and surprise billing in hospitals still lives!...
Read More »Something to keep in Mind when you enroll in Medicare Advantage Plans
It is not a dirty or hidden little secret. Insurance companies offering MA plans do not tell you that once you are in their plan, you are there potentially forever. Returning to traditional Medicare is ok but, getting a Medigap Plans to supplement the gap may lead to rejection or much higher premiums if you choose to come back and especially if their are pre-existing conditions. The same as the Commercial MA companies, Medicare.gov websites are not always...
Read More »The New Pharmacy Price Transparency Rule Put Forth by President Trump
“The New Hospital Price Disclosure Rule Is Important, But Only A First Step,” Health Affairs, James C. Capretta, August 26, 2019 The new proposed regulation on hospital price transparency is an important step toward consumer-friendly price information. The regulation introduces into federal price transparency, requirements such as the concepts: of service standardization, consumer-friendly organization and terminology, and bundling of which all of are...
Read More »